This article is more than 5 years old. Information may no longer be current.

Fibromyalgia care guidelines stress nonpharmacologic intervention

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SAN DIEGO — Guidelines from three countries for the diagnosis, classification and clinical care regarding fibromyalgia focused on patient self-management of the condition, according to research presented at the American College of Rheumatology annual meeting.

Mary-Ann Fitzcharles, MB, ChB, MD, clinical rheumatologist, McGill University, Montreal, presented results from a combination of independently developed guidelines for fibromyalgia established in Canada, Germany and Israel.

She highlighted three aspects of the guidelines:

• Fibromyalgia is now fully recognized as a valid condition.
• The condition should be diagnosed after a full clinical examination and patient history with minimal laboratory testing.
• The ideal care is “patient-tailored treatment,” with all three guidelines emphasizing nonpharmacologic intervention.

“The major focus should be on self-management techniques,” Fitzcharles told Healio.com.

Disclosure: See the abstract for a full list of relevant financial disclosures.

For more information:

Fitzcharles MA. #838: Recommendations for the Classification and Diagnosis of Fibromyalgia Syndrome Provided by Independently Developed Evidence-Based Interdisciplinary Guidelines Spanning Three Continents. Presented at: the 2013 American College of Rheumatology Annual Meeting; Oct. 26-30, San Diego.